Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Juvenile temporal arteritis is a rare form of vasculitis, a group of conditions that cause inflammation of the blood vessels. Unlike the classic form of temporal arteritis, this condition is generally diagnosed in late childhood or early adulthood and only affects the temporal arteries (located at the lower sides of the skull, directly underneath the temple). Affected people often have no signs or symptoms aside from a painless nodule or lump in the temporal region. The exact underlying cause of the condition is unknown. It generally occurs sporadically in people with no family history of the condition. Juvenile temporal arteritis is often treated with surgical excision and rarely recurs.
Features include common findings: Elevated white blood cell count (increased total leukocyte count), Headache, and Skin nodule; and sometimes findings: Conjunctivitis, Increased total eosinophil count, and Allergic rhinitis.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 1 | Elevated white blood cell count (increased total leukocyte count) |
Biomarker and diagnostic research for juvenile temporal arteritis has been reported in the published literature.
Phenotype severity distribution: 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for juvenile temporal arteritis.
130 publications have been identified in PubMed for juvenile temporal arteritis. Research spans Review / Meta-Analysis (48%), Epidemiology / Natural History (17%), and Diagnostic / Biomarker (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 63 | 48% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 1:58 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Brain and nerves |
1 |
Headache |
Skin | 1 | Skin nodule |
Eyes | 1 | Conjunctivitis |
22 |
17% |
Testing and diagnosis research | 14 | 11% |
Patient case studies | 11 | 8% |
Clinical study results | 8 | 6% |
Laboratory research | 6 | 5% |
Other research | 4 | 3% |
New treatment approaches | 2 | 2% |
Kwon OC (2026). [PMID: 41560383](https://pubmed.ncbi.nlm.nih.gov/41560383/). *Yonsei Med J*. [Diagnostic / Biomarker]
Ryalat A (2026). [PMID: 41922039](https://pubmed.ncbi.nlm.nih.gov/41922039/). *Neurol Clin*. [Review / Meta-Analysis]
Glynn T (2026). [PMID: 41772926](https://pubmed.ncbi.nlm.nih.gov/41772926/). *Med J Aust*. [Case Report / Case Series]
Chapron L (2026). [PMID: 41570312](https://pubmed.ncbi.nlm.nih.gov/41570312/). *Retina*. [Diagnostic / Biomarker]
Beirão TMBDM (2026). [PMID: 41524215](https://pubmed.ncbi.nlm.nih.gov/41524215/). *J Clin Rheumatol*. [Review / Meta-Analysis]
Yazici Y (2026). [PMID: 41070948](https://pubmed.ncbi.nlm.nih.gov/41070948/). *Curr Opin Rheumatol*. [Review / Meta-Analysis]
Dejaco C (2026). [PMID: 41812194](https://pubmed.ncbi.nlm.nih.gov/41812194/). *N Engl J Med*. [Review / Meta-Analysis]
Kermani TA (2026). [PMID: 42114096](https://pubmed.ncbi.nlm.nih.gov/42114096/). *Ann Intern Med*. [Review / Meta-Analysis]
Regola F (2026). [PMID: 41328604](https://pubmed.ncbi.nlm.nih.gov/41328604/). *Clin Exp Rheumatol*. [Review / Meta-Analysis]
Schmidt WA (2026). [PMID: 41923480](https://pubmed.ncbi.nlm.nih.gov/41923480/). *Expert Opin Pharmacother*. [Review / Meta-Analysis]